Evoke Pharma Receives Notice of Allowance from USPTO for a Patent Related to GIMOTIGlobeNewsWire • 09/20/22
Evoke Pharma to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/06/22
Evoke Pharma and EVERSANA Expand Patient Access to GIMOTI® With New Telehealth SolutionGlobeNewsWire • 08/16/22
Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
Evoke Pharma Recognizes Gastroparesis Awareness Month through its Support of The International Foundation for Gastrointestinal Disorders (IFFGD)GlobeNewsWire • 08/01/22
Evoke Pharma Regains Compliance with Nasdaq Listing Requirements and Provides Financial UpdateGlobeNewsWire • 06/08/22
Real-World Data Analysis Reveals a Lower Risk of Tardive Dyskinesia (TD) with Metoclopramide than Previously ReportedGlobeNewsWire • 05/23/22
Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22
Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/09/22